ENTA logo

Enanta Pharmaceuticals (ENTA) Accounts Payable

Annual Accounts Payable

$4.10 M
-$1.90 M-31.72%

30 September 2023

ENTA Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Payable

$10.68 M
+$3.95 M+58.71%

30 June 2024

ENTA Quarterly Accounts Payable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ENTA Accounts Payable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-+160.6%
3 y3 years-57.0%+11.9%
5 y5 years-38.8%+59.6%

ENTA Accounts Payable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-57.0%at low-9.2%+757.4%
5 y5 years-57.0%at low-9.2%+757.4%
alltimeall time-57.0%+623.9%-9.2%+1786.0%

Enanta Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
June 2024
-
$10.68 M(+58.7%)
Mar 2024
-
$6.73 M(-27.9%)
Dec 2023
-
$9.33 M(+127.6%)
Sept 2023
$4.10 M(-31.7%)
$4.10 M(-48.3%)
June 2023
-
$7.93 M(-32.6%)
Mar 2023
-
$11.76 M(+170.2%)
Dec 2022
-
$4.35 M(-27.5%)
Sept 2022
$6.00 M(-37.1%)
$6.00 M(+381.9%)
June 2022
-
$1.25 M(-79.2%)
Mar 2022
-
$5.99 M(-23.7%)
Dec 2021
-
$7.84 M(-17.8%)
Sept 2021
$9.54 M(+66.3%)
$9.54 M(+61.8%)
June 2021
-
$5.89 M(+3.4%)
Mar 2021
-
$5.70 M(-9.6%)
Dec 2020
-
$6.30 M(+9.9%)
Sept 2020
$5.74 M(-14.2%)
$5.74 M(-5.5%)
June 2020
-
$6.07 M(+2.2%)
Mar 2020
-
$5.95 M(-9.9%)
Dec 2019
-
$6.60 M(-1.4%)
Sept 2019
$6.69 M(+41.0%)
$6.69 M(+2.8%)
June 2019
-
$6.50 M(-26.8%)
Mar 2019
-
$8.88 M(+58.0%)
Dec 2018
-
$5.62 M(+18.5%)
Sept 2018
$4.75 M
$4.75 M(-3.2%)
June 2018
-
$4.90 M(+4.4%)
DateAnnualQuarterly
Mar 2018
-
$4.70 M(+43.7%)
Dec 2017
-
$3.27 M(-12.0%)
Sept 2017
$3.71 M(+10.0%)
$3.71 M(-32.3%)
June 2017
-
$5.49 M(+35.3%)
Mar 2017
-
$4.06 M(+107.8%)
Dec 2016
-
$1.95 M(-42.2%)
Sept 2016
$3.38 M(+118.9%)
$3.38 M(+65.2%)
June 2016
-
$2.04 M(-20.5%)
Mar 2016
-
$2.57 M(-7.0%)
Dec 2015
-
$2.77 M(+79.3%)
Sept 2015
$1.54 M(-17.7%)
$1.54 M(-4.4%)
June 2015
-
$1.61 M(-31.1%)
Mar 2015
-
$2.34 M(+313.2%)
Dec 2014
-
$567.00 K(-69.7%)
Sept 2014
$1.87 M(+26.5%)
$1.87 M(+46.0%)
June 2014
-
$1.28 M(-37.1%)
Mar 2014
-
$2.04 M(+143.0%)
Dec 2013
-
$840.00 K(-43.3%)
Sept 2013
$1.48 M(-20.0%)
$1.48 M(+61.3%)
June 2013
-
$918.00 K(-61.3%)
Mar 2013
-
$2.37 M(+33.7%)
Dec 2012
-
$1.77 M(-4.2%)
Sept 2012
$1.85 M(+227.0%)
$1.85 M(+122.2%)
June 2012
-
$833.00 K(+47.2%)
Sept 2011
$566.00 K
$566.00 K

FAQ

  • What is Enanta Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly accounts payable year-on-year change?

What is Enanta Pharmaceuticals annual accounts payable?

The current annual accounts payable of ENTA is $4.10 M

What is the all time high annual accounts payable for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual accounts payable is $9.54 M

What is Enanta Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of ENTA is $10.68 M

What is the all time high quarterly accounts payable for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly accounts payable is $11.76 M

What is Enanta Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, ENTA quarterly accounts payable has changed by +$6.58 M (+160.56%)